Bloody diarrhea, fever, and pancytopenia in a patient with active ulcerative colitis

Annals of Allergy, Asthma and Immunology

Volumn 90, Issue 4, 2003, Pages 383-388

  Jani, Alpa L ^a   Hamilos, Daniel ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE ANTIBODY;

ABDOMINAL PAIN; ADULT; ANAMNESIS; ARTICLE; AUTOIMMUNITY; BLOOD ANALYSIS; BODY BUILD; CASE REPORT; CELL COUNT; CLINICAL TRIAL; COLOR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; ERYTHROCYTE; FEMALE; FEVER; HOSPITAL; HUMAN; LABORATORY; NEUTROPENIA; OCCULT BLOOD; OROPHARYNX; PANCYTOPENIA; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TEMPERATURE; TIME; ULCERATIVE COLITIS;

EID: 0037391861     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61820-0     Document Type: Article

References (39)

1. Young NS, Maciejewski JP. Aplastic anemia. In: Hoffman R, Berry E, Shattil S, et al, editors. Hematology: Basic Principles and Practice. New York: Churchill Livingstone, 2000:297-331.
2. Dale DC. Neutropenia and neutrophilia. In: Butler E, Coller B, Lichtman M, Kipps T, et al, editors. William's Hematology, 6th ed. St. Louis, MO: McGraw-Hill, 2001:823-834.
3. Bruin MC, von dem Borne AE, Rienk YJ, et al. Neutrophil antibody specificity in different types of childhood autoimmune neutropenia. Blood 1999;94:1797-1802.
4. Logue GL, Shastri KA, Laughlin M, et al. Idiopathic neutropenia: antineutrophil antibodies and clinical correlations. Am J Med 1991;90:211-216.
5. Rustagi PK, Han T, Ziolkowski L, et al. Granulocyte antibodies in leukaemic chronic lymphoproliferative disorders. Br J Hematol 1987;66:461-465.
6. Rustagi PK, Currie MS, Logue GL. Complement-activating antineutrophil antibody in systemic lupus erythematosus. Am J Med 1985;78:971-977.
7. Starkebaum G, Arend WP, Nardella FA, Gavin SE. Characterization of immune complexes and immunoglobulin G antibodies reactive with neutrophils in the sera of patients with Felty's syndrome. J Lab Clin Med 1980;96:238-251.
8. Stevens C, Peppercorn M, Grand R. Crohn's disease associated with autoimmune neutropenia. J Clin Gastroenterol 1991;13: 328-330.
9. Shastri K, Logue G. Autoimmune neutropenia. Blood 1993;81: 1984-1995.
10. Roozendaal C, Kallenberg CG. Are anti-neutrophil cytoplasmic antibodies clinically useful in inflammatory bowel disease? Clin Exp Immunol 1999;116:206-213.
11. Saxon A, Shanahan F, Landers C, et al. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990;86: 202-210.
12. Rump JA, Scholmerich J, Gross V, et al. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiology 1990;181:406-413.
13. Eggena M, Cohavy O, Parseghian M, et al. Identification of histone H1 as a cognate antigen of the ulcerative colitis-associated marker antibody pANCA. J Autoimmun 2000;14: 83-97.
14. Sobajima J, Ozaki S, Osakada F, et al. Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2. Clin Exp Immunol 1997;107:135-140.
15. Terjung B, Herog V, Worman HJ, et al. Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins. Hepatology 1998;28: 332-340.
16. Terjung B, Spengler U, Sauerbruch T, Worman H. Atypical p-ANCA in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines. Gastroenterology 2000;119:310-332.
17. Harmon D, Weitzman S, Stossel T. The severity of immune neutropenia correlates with the maturational specificity of antineutrophil antibodies. Br J Haematol 1984;58:209-215.
18. Currie M, Weinberg J, Rustagi P, et al. Antibodies to granulocyte precursors in selective myeloid hypoplasia and other suspected autoimmune neutropenias: use of HL-60 cells as targets. Blood 1987;69:529-536.
19. Nielsen O, Vainer B, Madsen S, et al. Established and emerging biological activity markers of inflammatory bowel disease. Am J Gastroenterol 2000;95:359-367.
20. Sobajima J, Ozaki S, Okazaki T, et al. Anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: anti-cathepsin G and a novel antibody correlate with a refractory type. Clin Exp Immunol 1996;105:120-124.
21. Sandborn WJ, Landers CJ, Tremaine WJ, Targan SR. Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study. Mayo Clin Proc 1996;71:431-436.
22. Lombardi G, Annese V, Piepoli A, et al. Antineutrophil cytoplasmic antibodies in inflammatory bowel disease: clinical role and review of the literature. Dis Colon Rectum 2000;43: 999-1007.
23. Vasílíauskas EA, Plevy SE, Landers CJ, et al. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup. Gastroenterology 1996;110: 1810-1819.
24. Roozendaal C, Pogany K, Horst G, et al. Does analysis of the antigenic specificities of anti-neutrophil cytoplasmic antibodies contribute to their clinical significance in inflammatory bowel disease? Scand J Gastroenterol 1999;11:1123-1131.
25. Reumaux D, Colombel J, Duclos B, et al. Antineutrophil cytoplasmic auto-antibodies in sera from patients with ulcerative colitis after proctocolectomy with ileo-anal anastomosis. Adv Exp Med Biol 1993;336:523-525.
26. Patel RT, Stokes R, Birch D, et al. Influence of total colectomy on serum antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Br J Surg 1994;81:724-726.
27. Yang P, Oresland T, Jarnerot G, et al. Perinuclear antineutrophil cytoplasmic antibody in pouchitis after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Scand J Gastroenterol 1996;31:594-598.
28. Vecchi M, Gionchetti P, Bianchi MB, et al. p-ANCA and development of pouchitis in ulcerative colitis patients after proctocolectomy and ileoanal pouch anastomosis. Lancet 1994; 344:886-887.
29. Brett PM, Yasuda N, Yiannakou JY, et al. Genetic and immunological markers in pouchitis. Eur J Gastroenterol Hepatol 1996;8:951-955.
30. Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals. in vitro. Proc Natl Acad Sci USA 1990;87:4115-4119.
31. Mulder AH, Heeringa P, Brouwer E, et al. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a FcγRII-dependent process. Clin Exp Immunol 1994;98: 270-278.
32. Heeringa P, Brouwer E, Tervaert JW, et al. Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis. Kidney Int 1998;53:253-263.
33. Gionchetti P, Vecchi M, Rizzello F, et al. Lack of effect of antineutrophil cytoplasmic antibodies associated with ulcerative colitis on superoxide anion production from neutrophils. Gut 1997;40:102-104.
34. Hunter JD, Logue GL, Joyner JT. Autoimmune neutropenia in Hodgkin's disease. Arch Int Med 1982;142:386-388.
35. Hanrahan EM Jr, Miller SR. Effect of splenectomy in Felty's syndrome. J Am Med Assoc 1932;99:1247-1250.
36. Laszlo J, Jones R, Silberman HR, Banks PM. Splenectomy for Felty's syndrome. Clinicopathological study of 27 patients. Arch Int Med 1978;138:597-602.
37. Sheth SB, Crowley JP. Splenectomy for Felty's syndrome. R I Med J 1985;68:275-278.
38. Blumfelder TM, Logue GL, Shimm DS. Felty's syndrome: effects of splenectomy upon granulocyte count and granulocyte-associated IgG. Ann Intern Med 1981;94:623-628.
39. Imoto S, Hashimoto M, Miyamoto M, et al. Response to granulocyte stimulating factor in an autoimmune neutropenic adult. Acta Haematol 1999;101:153-156.